【摘要】：豬瘟(Classical swine fever,CSF)是由豬瘟病毒(Classical swine fever virus,CSFV)引起的一種以高熱、出血和免疫抑制為典型特征的嚴(yán)重危害養(yǎng)豬業(yè)的重大傳染病,是世界動(dòng)物衛(wèi)生組織(OIE)規(guī)定的必須報(bào)告的疫病,對(duì)我國(guó)乃至全球的養(yǎng)豬業(yè)造成巨大的經(jīng)濟(jì)損失。CSFV屬于黃病毒科(Flaviviridae)瘟病毒屬(Pestivirus),是一種單股正鏈RNA病毒。目前對(duì)CSFV的致病機(jī)制雖有一定的研究,但對(duì)于CSFV在宿主細(xì)胞中感染復(fù)制的機(jī)制,以及免疫逃逸的致病機(jī)理仍缺乏全面深入的了解。由于病毒要建立持續(xù)性感染,必須利用宿主細(xì)胞中可調(diào)控蛋白合成、能量代謝、細(xì)胞存活生長(zhǎng)的關(guān)鍵信號(hào)通路。因此,探討CSFV感染的宿主細(xì)胞中參與調(diào)控細(xì)胞存活、蛋白合成和細(xì)胞自噬等過(guò)程的關(guān)鍵信號(hào)通路,闡明其參與CSFV復(fù)制增殖的機(jī)制,為豬瘟的防治提供新的靶點(diǎn)和理論依據(jù)。哺乳動(dòng)物雷帕霉素靶蛋白(mammalian target of rapamycin,mTOR)信號(hào)通路連接著從感應(yīng)能量和生長(zhǎng)因子到調(diào)控細(xì)胞存活生長(zhǎng)及大分子合成代謝的過(guò)程,除了在腫瘤發(fā)生發(fā)展中發(fā)揮重要的作用,也參與多種DNA、RNA病毒的感染復(fù)制,在病毒復(fù)制中扮演重要的角色。但對(duì)于CSFV與mTOR信號(hào)通路的關(guān)系,目前尚沒(méi)有明確報(bào)道。因此,本研究擬闡明CSFV對(duì)mTOR信號(hào)通路的調(diào)控,以及mTOR信號(hào)通路調(diào)控CSFV復(fù)制的分子機(jī)制,從mTOR的角度為解釋CSFV的復(fù)制和持續(xù)性感染提供新的理論依據(jù)。本研究首先利用細(xì)胞內(nèi)信號(hào)通路蛋白芯片技術(shù)以及western-blot等方法證實(shí)與未感染CSFV的細(xì)胞相比較,CSFV(石門(mén)強(qiáng)毒株)感染ST細(xì)胞能夠顯著抑制Akt/mTOR信號(hào)通路的激活,該抑制在6-24 h最為顯著,隨后逐漸恢復(fù),至48 h恢復(fù)至處理前水平。而CSFV結(jié)構(gòu)蛋白Ems、非結(jié)構(gòu)蛋白NS3、NS5A在抑制Akt/mTOR信號(hào)通路的激活中發(fā)揮重要的作用。為了探討Akt/mTOR信號(hào)通路對(duì)CSFV自身復(fù)制的影響,利用mTOR抑制劑rapamycin和激活劑insulin改變宿主細(xì)胞mTOR通路活性后感染CSFV,western-blot和熒光定量PCR等結(jié)果表明在24 h內(nèi),rapamycin雖抑制細(xì)胞增殖但顯著促進(jìn)CSFV的復(fù)制;而insulin促進(jìn)細(xì)胞增殖但顯著抑制CSFV復(fù)制;值得注意的是在48 h時(shí)這一調(diào)控趨勢(shì)并不存在;我們推測(cè):CSFV感染抑制mTOR/S6K1,導(dǎo)致S6K1通過(guò)IRS(胰島素受體)誘導(dǎo)Akt負(fù)反饋激活,進(jìn)而抵消了由mTOR抑制引起的病毒復(fù)制。隨后,我們進(jìn)一步探討mTOR上游Akt對(duì)CSFV復(fù)制的影響;分別應(yīng)用Akt特異性抑制劑(LY294002)抑制Akt活性,以及Akt激活劑(SC79)激活A(yù)kt后感染CSFV,熒光定量PCR結(jié)果表明,與未經(jīng)處理的ST細(xì)胞相比較,抑制Akt活性能夠在72h內(nèi)持續(xù)上調(diào)CSFV基因組拷貝數(shù);而激活A(yù)kt則持續(xù)降低CSFV基因組拷貝數(shù)。與單獨(dú)改變mTOR活性引起的只在24 h內(nèi)調(diào)控病毒復(fù)制有所不同,這很有可能是由于CSFV感染引起mTOR抑制誘導(dǎo)Akt負(fù)反饋激活以及Akt作為mTOR上游引起比mTOR更強(qiáng)的作用導(dǎo)致。上述研究結(jié)果表明Akt/mTOR信號(hào)通路可負(fù)調(diào)控CSFV的復(fù)制,也提示CSFV感染ST細(xì)胞可能通過(guò)誘導(dǎo)Akt負(fù)反饋激活來(lái)調(diào)控病毒復(fù)制和維持細(xì)胞穩(wěn)態(tài)。為了深入探究Akt/mTOR信號(hào)通路負(fù)調(diào)控CSFV復(fù)制的分子機(jī)制,本研究以mTOR信號(hào)通路下游調(diào)控自噬及蛋白合成的兩個(gè)效應(yīng)分子ULK1和S6K1為切入點(diǎn),應(yīng)用透射電鏡、western-blot、共聚焦顯微鏡、LC3雙熒光自噬慢病毒、IFA檢測(cè)病毒滴度以及熒光定量PCR等方法證明CSFV感染能夠增強(qiáng)ST細(xì)胞的自噬流,隨后應(yīng)用rapamycin和insulin以及ULK1抑制劑抑制或激活mTOR/ULK1活性,結(jié)果顯示自噬被顯著促進(jìn)或抑制,而病毒的復(fù)制被相應(yīng)的促進(jìn)或抑制。證明CSFV通過(guò)mTOR/ULK1依賴的信號(hào)通路誘導(dǎo)細(xì)胞自噬進(jìn)而促進(jìn)病毒復(fù)制。另一方面,應(yīng)用雙熒光素酶報(bào)告基因系統(tǒng),通過(guò)構(gòu)建含CSFV內(nèi)部核糖體進(jìn)入位點(diǎn)(IRES)的螢火蟲(chóng)熒光素酶重組載體(CSFV-IRES),應(yīng)用過(guò)表達(dá)和shRNA干擾等方法證明過(guò)表達(dá)和干擾表達(dá)S6K1能夠抑制和促進(jìn)CSFV-IRES蛋白驅(qū)動(dòng)活性,隨后病毒滴度檢測(cè)和熒光定量PCR結(jié)果顯示,過(guò)表達(dá)和干擾表達(dá)S6K1能抑制和促進(jìn)CSFV復(fù)制。接著,利用免疫共沉淀、核糖體分離技術(shù)以及熒光定量PCR等方法證實(shí),CSFV感染ST細(xì)胞能抑制mTOR/S6K1磷酸化激活,進(jìn)而促進(jìn)S6K1與真核起始因子3(elF3A)的結(jié)合,釋放CSFV-IRES與eIF3競(jìng)爭(zhēng)結(jié)合40S核糖體,促進(jìn)病毒mRNA翻譯。Akt/mTOR信號(hào)通路抑制能夠?qū)е录?xì)胞增殖抑制和細(xì)胞凋亡,而在體外,CSFV感染宿主細(xì)胞通常不抑制細(xì)胞增殖和凋亡。因此結(jié)合以上的研究,我們探討CSFV感染抑制Akt/mTOR信號(hào)通路是否通過(guò)誘導(dǎo)Akt負(fù)反饋維持細(xì)胞增殖和抗凋亡,以便于為病毒復(fù)制提供穩(wěn)定的細(xì)胞內(nèi)環(huán)境。通過(guò)western-blot檢測(cè)CSFV感染后Akt磷酸化水平,結(jié)果表明Akt磷酸化水平先降低后恢復(fù),進(jìn)一步證實(shí)CSFV感染ST細(xì)胞可誘導(dǎo)Akt負(fù)反饋激活。隨后流式細(xì)胞檢測(cè)發(fā)現(xiàn)CSFV感染初期能夠?qū)⒓?xì)胞周期阻滯于G0/G1期,而48 h后沒(méi)有阻滯作用;另外使用Akt抑制劑LY294002單獨(dú)或與CSFV共同作用ST細(xì)胞,SRB實(shí)驗(yàn)檢測(cè)細(xì)胞增殖,結(jié)果顯示抑制Akt活性同時(shí)感染CSFV較單獨(dú)抑制Akt或單獨(dú)感染CSFV時(shí),對(duì)細(xì)胞增殖的抑制顯著增強(qiáng),間接提示CSFV感染誘導(dǎo)宿主細(xì)胞Akt負(fù)反饋激活,維持宿主細(xì)胞增殖,而一旦Akt被抑制劑持續(xù)抑制,感染CSFV誘導(dǎo)的Akt負(fù)反饋激活也被相應(yīng)地抑制,因此不能維持細(xì)胞增殖。接著,細(xì)胞凋亡檢測(cè)結(jié)果顯示,抑制Akt活性同時(shí)感染CSFV較單獨(dú)抑制Akt或單獨(dú)感染CSFV時(shí)對(duì)細(xì)胞引起的凋亡率更大,證明CSFV誘導(dǎo)的負(fù)反饋激活能夠維持細(xì)胞存活。最后,以Akt抑制劑與CSFV共同作用ST細(xì)胞至24 h、48 h、72 h,熒光定量PCR檢測(cè)結(jié)果表明,與單獨(dú)感染CSFV細(xì)胞相比較,在72 h內(nèi)持續(xù)阻斷Akt能夠持續(xù)上調(diào)病毒基因組拷貝數(shù),進(jìn)一步提示CSFV感染引起Akt負(fù)反饋激活,進(jìn)而維持病毒的復(fù)制。以上結(jié)果充分證實(shí)CSFV感染ST細(xì)胞誘導(dǎo)Akt負(fù)反饋激活的存在并且能夠維持細(xì)胞存活和病毒自身復(fù)制。綜上,本研究全面證實(shí)CSFV感染宿主細(xì)胞能夠通過(guò)劫持mTOR信號(hào)通路以維持病毒復(fù)制和細(xì)胞存活,為以Akt/mTOR激活防治豬瘟提供新的靶點(diǎn)和思路。
[Abstract]:Classical swine fever (CSF) is a serious infectious disease caused by classical swine fever virus (CSFV), which is characterized by high fever, hemorrhage and immunosuppression. It is an epidemic disease that must be reported by the World Organization for Animal Health (OIE). It has caused tremendous damage to the pig industry in China and even the world. CSFV belongs to the genus Pestivirus of Flaviviridae. It is a single stranded positive-stranded RNA virus. Although the pathogenesis of CSFV has been studied, the mechanism of infection and replication of CSFV in host cells and the pathogenesis of immune escape are still poorly understood. Continuous infection requires the use of key signaling pathways that regulate protein synthesis, energy metabolism, and cell survival and growth in host cells. The mammalian target of rapamycin (mTOR) signaling pathway links the processes from induction energy and growth factors to regulation of cell survival, growth and macromolecule synthesis and metabolism. Infection replication plays an important role in viral replication. However, the relationship between CSFV and mTOR signaling pathway has not been clearly reported. Therefore, this study aims to elucidate the regulation of CSFV on mTOR signaling pathway and the molecular mechanism of mTOR signaling pathway on CSFV replication, providing an explanation for CSFV replication and persistent infection from the perspective of mTOR. In this study, compared with non-CSFV-infected cells, CSFV-infected ST cells significantly inhibited the activation of Akt/mTOR signaling pathway. The inhibition was most significant at 6-24 h, then gradually recovered until 48 h. In order to investigate the effect of Akt/mTOR signaling pathway on CSFV self-replication, we used mTOR inhibitor rapamycin and activator insulin to change the activity of host cell mTOR pathway and infected CSFV, Western-blot and fluorescence. Quantitative PCR and other results showed that rapamycin inhibited cell proliferation but significantly promoted CSFV replication within 24 hours; insulin promoted cell proliferation but significantly inhibited CSFV replication; it is noteworthy that this regulatory trend did not exist at 48 hours; we speculated that CSFV infection inhibited mTOR/S6K1, resulting in S6K1 inducing Akt negative reaction via IRS (insulin receptor). Subsequently, we further investigated the effect of Akt upstream of mTOR on CSFV replication; Akt specific inhibitor (LY294002) was used to inhibit Akt activity; and Akt activator (SC79) was used to activate Akt to infect CSFV. Fluorescence quantitative PCR results showed that it was inhibited compared with untreated ST cells. Akt-producing activity could continuously up-regulate the copy number of CSFV genome within 72 hours, while activation of Akt could continuously decrease the copy number of CSFV genome. These results suggest that the Akt/mTOR signaling pathway can negatively regulate the replication of CSFV, and that ST cells infected with CSFV may regulate virus replication and maintain cell homeostasis by inducing Akt negative feedback activation. Two effector molecules ULK1 and S6K1, which regulate autophagy and protein synthesis downstream of the pathway, were used as entry points. TEM, Western-blot, confocal microscopy, LC3 double fluorescent autophagy lentivirus, IFA detection of virus titer and fluorescence quantitative PCR proved that CSFV infection could enhance the autophagy of ST cells. K1 inhibitors inhibit or activate mTOR/ULK1 activity, indicating that autophagy is significantly promoted or inhibited, whereas virus replication is correspondingly promoted or inhibited. It is demonstrated that CSFV induces cell autophagy through mTOR/ULK1-dependent signaling pathway and promotes virus replication. On the other hand, double luciferase reporter gene system is used to construct CSFV-containing interior. The fluorescein enzyme recombinant vector (CSFV-IRES) at the ribosomal entry site (IRES) was used to demonstrate that the overexpression and interference of S6K1 could inhibit and promote the drive activity of CSFV-IRES protein. The results of viral titer detection and fluorescence quantitative PCR showed that overexpression and interference of S6K1 could inhibit and promote CSFV-IRES protein. FV replication. Immunocoprecipitation, ribosome isolation and fluorescence quantitative PCR confirmed that CSFV-infected ST cells inhibited the phosphorylation of mTOR/S6K1, thereby facilitating the binding of S6K1 to eukaryotic initiation factor 3 (elF3A), releasing CSFV-IRES to compete with eIF3 to bind to 40S ribosomes and promoting the translation of viral mRNA. Akt/mTOR signaling pathway was inhibited. CSFV infection usually does not inhibit cell proliferation and apoptosis in vitro. Therefore, in combination with the above studies, we explore whether CSFV infection inhibits Akt/mTOR signaling pathway by inducing Akt negative feedback to maintain cell proliferation and anti-apoptosis in order to provide stable details for virus replication. Akt phosphorylation was detected by Western-blot. The results showed that Akt phosphorylation decreased first and then recovered. It was further confirmed that CSFV-infected ST cells could induce Akt negative feedback activation. Using Akt inhibitor LY294002 alone or in conjunction with CSFV, the proliferation of ST cells was detected by SRB assay. The results showed that inhibition of Akt activity and infection with CSFV increased significantly compared with inhibition of Akt alone or infection with CSFV alone. Once Akt was inhibited by the inhibitor, the negative feedback activation of Akt induced by CSFV was inhibited accordingly, so the cell proliferation could not be maintained. Next, the results of cell apoptosis detection showed that the rate of cell apoptosis induced by inhibiting Akt activity and infecting CSFV at the same time was higher than that induced by inhibiting Akt alone or CSFV alone. Finally, the results of fluorescence quantitative PCR assay showed that continuous blockade of Akt for 72 hours could continuously increase the number of viral genomic copies compared with single infection of CSFV cells, suggesting that CSFV infection could cause negative feedback activation of Akt and consequently maintain the disease. These results fully confirm that CSFV-infected ST cells induce Akt negative feedback activation and can maintain cell survival and virus replication. In conclusion, this study fully confirms that CSFV-infected host cells can maintain virus replication and cell survival by hijacking the mTOR signaling pathway, providing a basis for the prevention and treatment of swine fever with Akt/mTOR activation. New targets and ideas.
【學(xué)位授予單位】：揚(yáng)州大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：S852.651

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 潘智;張令強(qiáng);蔣繼志;賀福初;;mTOR的研究進(jìn)展[J];細(xì)胞生物學(xué)雜志;2006年03期

2 Nan Wang;Ruijuan Wu;Xiaoheng Cheng;Jin Jin;Zongchao Jia;Jimin Zheng;;New insights into mTOR structure and regulation[J];Chinese Science Bulletin;2014年24期

3 陳j,張紅鋒;mTOR信號(hào)通路與癌癥治療[J];生命的化學(xué);2005年02期

4 張超;章雄文;丁健;;Akt-mTOR的互動(dòng)與癌癥的發(fā)生[J];生命科學(xué);2007年01期

5 張娟;李欣;楊麗;田朗;邢曉為;黃利華;楊作成;;柯薩奇病毒B3感染HeLa細(xì)胞后mTOR通路部分信號(hào)蛋白表達(dá)的變化[J];中國(guó)現(xiàn)代醫(yī)學(xué)雜志;2014年11期

6 林駿;白曉春;;mTOR信號(hào)通路與“炎-癌”轉(zhuǎn)變[J];生物化學(xué)與生物物理進(jìn)展;2014年01期

7 王怡;張姣姣;楊煒蓉;王莉娟;王鮮忠;;哺乳動(dòng)物雷帕霉素靶蛋白(mTOR)信號(hào)通路與生理功能的調(diào)節(jié)研究進(jìn)展[J];中國(guó)畜牧獸醫(yī);2012年04期

8 鄭杰;;mTOR信號(hào)途徑與腫瘤[J];生命科學(xué);2006年03期

9 劉家宏;徐小潔;符靜;范忠義;呂朝暉;陸菊明;肖文華;朱建華;葉棋濃;;慢病毒介導(dǎo)的mTOR敲低肝癌細(xì)胞株HepG2的構(gòu)建及初步功能檢測(cè)[J];生物技術(shù)通訊;2013年04期

10 陳洪菊;屈藝;母得志;;mTOR信號(hào)通路的生物學(xué)功能[J];生命的化學(xué);2010年04期

相關(guān)會(huì)議論文 前10條

1 Huayong Zhou;Yi Wang;Lanping Ma;Xin Wang;Lin Chen;Yi Chen;Jian Ding;Tao Meng;Linhua Meng;Jingkang Shen;;Novel indazole-based derivatives as PI3K/mTOR dual inhibitors[A];2012長(zhǎng)三角藥物化學(xué)研討會(huì)論文集[C];2012年

2 ;Activation of mTOR Pathway Confers Adverse Outcome in Nonsmall Cell Lung Carcinoma[A];中華醫(yī)學(xué)會(huì)第五屆全國(guó)胸部腫瘤及內(nèi)窺鏡學(xué)術(shù)會(huì)議論文匯編[C];2011年

3 韓進(jìn)松;陳穎;宋云龍;呂加國(guó);周有駿;朱駒;;Structure-Based Design,Synthesis,and Antitumor Activities of Novel Water-soluble Dual Inhibitors of PI3K and mTOR[A];2012長(zhǎng)三角藥物化學(xué)研討會(huì)論文集[C];2012年

4 姜偉;王修啟;束剛;江青艷;楊舟;;mTOR信號(hào)通路及其對(duì)骨骼肌蛋白質(zhì)合成的影響[A];全國(guó)動(dòng)物生理生化第十一次學(xué)術(shù)交流會(huì)論文摘要匯編[C];2010年

5 管坤良;;The TSC-mTOR pathway in cell growth and cancer[A];2009醫(yī)學(xué)前沿論壇暨第十一屆全國(guó)腫瘤藥理與化療學(xué)術(shù)會(huì)議論文集[C];2009年

6 Hai Huang;Xin Liu;;The molecular mechanism of apoptosis in human gastric cancer SGC-7901 cells induced by evodiamine inhibition mTOR signal pathway[A];中國(guó)生物化學(xué)與分子生物學(xué)會(huì)第十屆會(huì)員代表大會(huì)暨全國(guó)學(xué)術(shù)會(huì)議摘要集[C];2010年

7 孟祥斐;郁金泰;譚蘭;;靶向作用于mTOR治療癲癇[A];山東省2013年神經(jīng)內(nèi)科學(xué)學(xué)術(shù)會(huì)議暨中國(guó)神經(jīng)免疫大會(huì)2013論文匯編[C];2013年

8 曾軍英;胡興;皮建輝;;Cytotoxic Elimination of Chemoresistant Pancreatic Cancer Stem Cells by Combined Inhibition of RON and mTOR Signaling Pathways[A];湖南省生理科學(xué)會(huì)2013年度學(xué)術(shù)年會(huì)論文摘要匯編[C];2013年

9 ;mTOR enhancement of STIM1-mediated store-operated Ca~(2+) signaling constrains tumor development[A];第九屆全國(guó)鈣信號(hào)和細(xì)胞功能研討會(huì)論文摘要集[C];2012年

10 ;mTOR.rictor Is Required by the Development of Mouse One-cell Stage Embryos[A];第九屆全國(guó)酶學(xué)學(xué)術(shù)討論會(huì)暨鄒承魯誕辰85周年紀(jì)念會(huì)論文摘要集[C];2008年

相關(guān)重要報(bào)紙文章 前2條

1 駐京記者 李瑤;mTOR提供癌癥治療新思路[N];醫(yī)藥經(jīng)濟(jì)報(bào);2010年

2 本報(bào)記者 白毅;mTOR信號(hào)通路為腫瘤治療提供新靶點(diǎn)[N];中國(guó)醫(yī)藥報(bào);2010年

相關(guān)博士學(xué)位論文 前10條

1 劉倫志;腎素抑制劑對(duì)高糖誘導(dǎo)足細(xì)胞凋亡與mTOR表達(dá)的影響[D];武漢大學(xué);2014年

2 李舒展;PGAM1在mTOR誘導(dǎo)腫瘤有氧糖酵解中的作用及機(jī)制研究[D];天津醫(yī)科大學(xué);2015年

3 叢江琳;MiR-634通過(guò)調(diào)控mTOR信號(hào)途徑抑制宮頸癌細(xì)胞增殖及誘導(dǎo)凋亡的實(shí)驗(yàn)研究[D];山東大學(xué);2015年

4 胡越;mTOR和細(xì)胞自噬在LPS誘導(dǎo)的急性肺損傷中分子調(diào)控機(jī)制的研究[D];浙江大學(xué);2016年

5 陳玲琳;調(diào)控mTOR信號(hào)通路對(duì)癲癇的作用及其機(jī)制研究[D];浙江大學(xué);2016年

6 黃暢;基于mTOR信號(hào)通路探討艾灸及艾煙對(duì)APP/PS1雙轉(zhuǎn)基因小鼠認(rèn)知障礙的影響及機(jī)制研究[D];北京中醫(yī)藥大學(xué);2017年

7 苗麗君;慢病毒介導(dǎo)的mTOR靶向抑制對(duì)肺腺癌A549細(xì)胞生物學(xué)功能的影響[D];鄭州大學(xué);2012年

8 曾梅;自我吞噬及mTOR信號(hào)在小鼠神經(jīng)瘤細(xì)胞分化過(guò)程中的作用[D];中國(guó)科學(xué)技術(shù)大學(xué);2008年

9 周樂(lè)杜;PI3K/Akt/mTOR信號(hào)通路在肝細(xì)胞癌發(fā)病機(jī)制中的作用及靶向干預(yù)研究[D];中南大學(xué);2010年

10 張慧;蛋白攝入水平對(duì)早產(chǎn)學(xué)習(xí)認(rèn)知能力及mTOR/S6K通路的影響[D];南方醫(yī)科大學(xué);2013年

相關(guān)碩士學(xué)位論文 前10條

1 閆斌;血清mTOR檢測(cè)對(duì)消化系統(tǒng)惡性腫瘤患者的臨床意義[D];內(nèi)蒙古大學(xué);2012年

2 王艮波;mTOR通路在氯化亞鐵誘導(dǎo)的外傷性癲癇大鼠模型額葉皮質(zhì)及海馬中的表達(dá)研究[D];福建醫(yī)科大學(xué);2015年

3 羅榮奎;肝臟血管平滑肌脂肪瘤的臨床病理特征及mTOR通路分析[D];復(fù)旦大學(xué);2014年

4 顧兵;腦出血后mTOR信號(hào)通路激活及雷帕霉素腦保護(hù)作用機(jī)制研究[D];蘇州大學(xué);2015年

5 張劍;食管鱗狀細(xì)胞癌中mTOR表達(dá)及其與癌癥惡性程度和患者機(jī)體免疫反應(yīng)水平相關(guān)性研究[D];青島大學(xué);2015年

6 周璇;mTOR信號(hào)通路在小鼠B淋巴細(xì)胞成熟及抗體產(chǎn)生中的作用及其機(jī)制[D];南方醫(yī)科大學(xué);2014年

7 楊雪帆;慈菇多糖對(duì)小鼠免疫功能及mTOR信號(hào)通路的影響[D];福建醫(yī)科大學(xué);2015年

8 夏傳友;組蛋白甲基化酶SMYD3在前列腺癌中mTOR通路的機(jī)制研究[D];山東大學(xué);2016年

9 王嘉禎;食管鱗癌細(xì)胞中LSD1與mTOR通路相互調(diào)控作用研究[D];鄭州大學(xué);2016年

10 張海環(huán);豬小腸賴氨酸轉(zhuǎn)運(yùn)體對(duì)氮源的響應(yīng)規(guī)律及mTOR信號(hào)通路的調(diào)控研究[D];吉林農(nóng)業(yè)大學(xué);2016年

，

本文編號(hào)：2233893